NCT00874328 2010-10-25A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)National Cancer Center, KoreaPhase 1/2 Unknown74 enrolled